TARCC, AHA Grants to Aide TTUHSC Researcher

Vijayan to study VDAC1 and mitophagy in Alzheimer’s disease

    Man sitting at desk next to computer screen
Murali Vijayan, Ph.D.
    
Murali Vijayan, Ph.D., an assistant professor in the Department of Internal Medicine at the Texas Tech University Health Sciences Center, has been awarded a research grant from the Texas Alzheimer’s Research and Care Consortium (TARCC) to investigate the role of Voltage-Dependent Anion Channel 1 (VDAC1) in Alzheimer’s disease.

The grant will support Vijayan’s research into how VDAC1 regulates mitophagy, a critical cellular process that helps maintain healthy mitochondria by removing dysfunctional mitochondria during periods of metabolic stress.

Mitochondrial dysfunction plays a significant role in the development of Alzheimer’s disease. By studying VDAC1, Vijayan aims to uncover novel mechanisms that contribute to this dysfunction, potentially leading to new therapeutic targets. The research will involve both in vitro and in vivo models to examine how disruptions in VDAC1 function may impair mitochondrial clearance and exacerbate neurodegeneration.

    scientist in laboratory looking through a microscope
Murali Vijayan, Ph.D.
    
In addition to the TARCC grant, Vijayan recently received a career development grant from the American Heart Association (AHA). The AHA award supports highly promising health care and academic professionals in the early years of their first professional appointment. Recipients use these grants to explore innovative questions and conduct pilot studies to provide preliminary data and the training necessary to assure the applicant’s future success as a research scientist.

“These two grants provide a unique opportunity to investigate the intersection of mitochondrial dysfunction in Alzheimer’s disease and develop innovative strategies to protect neurons and slow disease progression,” Vijayan added. “We are hopeful that our research will lead to meaningful advances in understanding and treating Alzheimer’s disease.”

Related Stories

Research

TTUHSC Researchers Seek Novel Therapies for Chronic Pain

The National Institute of Neurological Disorders and Stroke at the NIH recently awarded a $1.94 million grant to Mahmoud Salama Ahmed, Ph.D., and his project team from the Department of Pharmaceutical Sciences at TTUHSC. Jerry H. Hodge School of Pharmacy.

Research

TTUHSC and TTUHSC El Paso Named to National Academy of Inventors Top 100

For the third consecutive year in a row, the National Academy of Inventors (NAI) ranked the Texas Tech University System (TTU System) among the Top 100 U.S. Universities Granted Utility Patents for 2024. The TTU System, which includes Texas Tech University Health Sciences Center (TTUHSC) and TTUHSC El Paso, ranked 75th.

Research

TTUHSC Recognizes Student Research During Amarillo Research Symposium

More than 100 student and trainee researchers from the Texas Tech University Health Sciences Center (TTUHSC) presented research findings at the 2025 Student Research Day on April 11.

Recent Stories

Education

Santos Named Department of Surgery Chair for TTUHSC School of Medicine in Lubbock

As the new Department of Surgery chair for the School of Medicine in Lubbock, Ariel Santos, M.D., M.P.H., seeks to elevate TTUHSC’s role as the Hub of Surgery for West Texas.

Health

Covenant Health Brings Kidney Transplant Surgery Back to West Texas

The Kidney Transplant Program at Covenant Medical Center will provide life-changing opportunities for patients suffering from end-stage renal disease (ESRD) and chronic kidney conditions.

Education

U.S. News & World Report Ranks TTUHSC Schools Among Best for 2025 Graduate School Rankings

Several graduate programs at TTUHSC have been recognized in the 2025 U.S. News & World Report Best Graduate School Rankings, reaffirming the university’s continued excellence in health sciences education and training.